A hidden gem Catenin-α-1 is essential for Chikungunya virus infection

A hidden gem Catenin-α-1 is essential for Chikungunya virus infection

Bibliographic Details
Main Authors:	Sanchari Chatterjee, Bharat Bhusan Subudhi, Soma Chattopadhyay
Format:	Article
Language:	English
Published:	American Society for Microbiology 2023-12-01
Series:	Microbiology Spectrum
Subjects:	Chikungunya virus Catenin-α-1 CHIKV-nsP2 co-immunoprecipitation
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.02485-23

Similar Items

The threat of chikungunya in Oceania
by: John Aaskov, et al.
Published: (2013-06-01)

TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages
by: Chandan Mahish, et al.
Published: (2023-04-01)

ALTERAÇÕES TRANSCRICIONAIS PRECOCEMENTE ENVOLVIDAS NA PROGRESSÃO DE PACIENTES PARA DOENÇA ARTICULAR CRÔNICA PÓS-CHIKUNGUNYA
by: Mariana Severo Ramundo, et al.
Published: (2023-10-01)

Secondary Autochthonous Outbreak of Chikungunya, Southern Italy, 2017
by: Flavia Riccardo, et al.
Published: (2019-11-01)

Current Status of Chikungunya in India
by: The Translational Research Consortia (TRC) for Chikungunya Virus in India, et al.
Published: (2021-06-01)

Chikungunya Outbreak, French Polynesia, 2014
by: Maite Aubry, et al.
Published: (2015-04-01)

Cardiomyopathy and Death Following Chikungunya Infection: An Increasingly Common Outcome
by: Elizabeth M. Traverse, et al.
Published: (2021-06-01)

An Overview of Indian Biomedical Research on the Chikungunya Virus with Particular Reference to Its Vaccine, an Unmet Medical Need
by: Muhammed Muhsin Varikkodan, et al.
Published: (2023-06-01)

In silico study on anti-Chikungunya virus activity of hesperetin
by: Adrian Oo, et al.
Published: (2016-10-01)

Continuous Circulation of Chikungunya Virus during COVID-19 Pandemic in Jambi, Sumatra, Indonesia
by: Marsha Sinditia Santoso, et al.
Published: (2022-06-01)

Chikungunya Virus Infection in Blood Donors and Patients During Outbreak, Mandalay, Myanmar, 2019
by: Aung Kyaw Kyaw, et al.
Published: (2020-11-01)

Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease
by: Rebecca M. Broeckel, et al.
Published: (2019-10-01)

Seroprevalence of Chikungunya Virus after Its Emergence in Brazil
by: Juarez P. Dias, et al.
Published: (2018-04-01)

Chikungunya Virus: Priority Pathogen or Passing Trend?
by: Gerardo Montalvo Zurbia-Flores, et al.
Published: (2023-03-01)

The Tetraspanin CD81 Is a Host Factor for Chikungunya Virus Replication
by: Lisa Lasswitz, et al.
Published: (2022-06-01)

Computational approach to study the synthesis of noscapine and potential of stereoisomers against nsP3 protease of CHIKV
by: Prashant Singh, et al.
Published: (2019-12-01)

SAMHD1 Enhances Chikungunya and Zika Virus Replication in Human Skin Fibroblasts
by: Sineewanlaya Wichit
Published: (2020-06-01)

Influence of host genetic polymorphisms involved in immune response and their role in the development of Chikungunya disease: a review
by: W.J.P. Gotay, et al.
Published: (2023-09-01)

Current Strategies for Inhibition of Chikungunya Infection
by: Bharat Bhusan Subudhi, et al.
Published: (2018-05-01)

Prevalence of Malaria and Chikungunya Co-Infection in Febrile Patients: A Systematic Review and Meta-Analysis
by: Wanida Mala, et al.
Published: (2021-06-01)

Recent Progress in Vaccine Development Against Chikungunya Virus
by: Shan Gao, et al.
Published: (2019-12-01)

Mosquito Rasputin interacts with chikungunya virus nsP3 and determines the infection rate in Aedes albopictus
by: Jelke J. Fros, et al.
Published: (2015-09-01)

Luciferase Immunosorbent Assay Based on Multiple E Antigens for the Detection of Chikungunya Virus-Specific IgG Antibodies
by: Xiaoxia Li, et al.
Published: (2022-04-01)

Role of MicroRNAs in Bone Pathology during Chikungunya Virus Infection
by: Enakshi Roy, et al.
Published: (2020-10-01)

Ixchiq (VLA1553): The first FDA-approved vaccine to prevent disease caused by Chikungunya virus infection
by: Hinh Ly
Published: (2024-12-01)

Trigocherrierin A, a Potent Inhibitor of Chikungunya Virus Replication
by: Mélanie Bourjot, et al.
Published: (2014-03-01)

Severe Sepsis and Septic Shock Associated with Chikungunya Virus Infection, Guadeloupe, 2014
by: Amélie Rollé, et al.
Published: (2016-05-01)

Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approach
by: Muhammad Tahir ul Qamar, et al.
Published: (2018-10-01)

Comodulation of Dengue and Chikungunya Virus Infection During a Coinfection Scenario in Human Cell Lines
by: Debjani Taraphdar, et al.
Published: (2022-04-01)

Molecular Characterization of Autochthonous Chikungunya Cluster in Latium Region, Italy
by: Licia Bordi, et al.
Published: (2018-01-01)

Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors
by: Prateek Kumar, et al.
Published: (2019-08-01)

Dengue and chikungunya: future threats for Northern Europe?
by: Justine Laverdeur, et al.
Published: (2024-01-01)

Molecular characterization of chikungunya virus during the 2019 outbreak in the Democratic Republic of the Congo
by: Philippe Selhorst, et al.
Published: (2020-01-01)

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus
by: César López-Camacho, et al.
Published: (2019-04-01)

The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry
by: Jared Kirui, et al.
Published: (2021-07-01)

Decoding chikungunya virus non-structural protein 3 interacting partners in THP-1 derived infected macrophages through proteomic profiling
by: Priyanshu Srivastava, et al.
Published: (2024-03-01)

Performance Evaluation of VIDAS<sup>®</sup> Diagnostic Assays Detecting Anti-Chikungunya Virus IgM and IgG Antibodies: An International Study
by: Geovana M. Pereira, et al.
Published: (2023-07-01)

Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico
by: Young Chan Kim, et al.
Published: (2019-05-01)

Drug repurposing approach against chikungunya virus: an in vitro and in silico study
by: Bhagyashri Kasabe, et al.
Published: (2023-04-01)

Corrigendum: Drug repurposing approach against chikungunya virus: an in vitro and in silico study
by: Bhagyashri Kasabe, et al.
Published: (2023-06-01)